C. Anger

3.8k total citations · 1 hit paper
10 papers, 3.3k citations indexed

About

C. Anger is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, C. Anger has authored 10 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in C. Anger's work include Colorectal Cancer Treatments and Studies (4 papers), Genetic factors in colorectal cancer (3 papers) and Lung Cancer Treatments and Mutations (3 papers). C. Anger is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Genetic factors in colorectal cancer (3 papers) and Lung Cancer Treatments and Mutations (3 papers). C. Anger collaborates with scholars based in United Kingdom, United States and Switzerland. C. Anger's co-authors include Jing Hu, Julien Taı̈eb, David Neasham, Patrick Cheung, George Kafatos, Kimberly A. Lowe, Victoria Banks, Thomas Moehler, Laura Mitrofan and Bradley L. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Value in Health.

In The Last Decade

C. Anger

10 papers receiving 3.2k citations

Hit Papers

COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON... 2002 2026 2010 2018 2002 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
    2002 3.3k citations C. Anger, Jing Hu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Anger United Kingdom 3 2.6k 2.3k 945 471 167 10 3.3k
Mauro Zukin Brazil 13 2.8k 1.1× 2.4k 1.0× 748 0.8× 519 1.1× 207 1.2× 38 3.5k
Teresa Morán Spain 26 1.9k 0.7× 1.6k 0.7× 1.0k 1.1× 627 1.3× 145 0.9× 130 2.7k
Dae Ho Lee South Korea 27 2.9k 1.2× 2.4k 1.0× 940 1.0× 587 1.2× 192 1.1× 91 3.4k
Jennifer Tursi Italy 14 2.5k 1.0× 2.1k 0.9× 841 0.9× 681 1.4× 180 1.1× 25 3.2k
Annetta Krebs United States 8 1.9k 0.7× 2.0k 0.8× 723 0.8× 395 0.8× 131 0.8× 8 2.8k
Riyaz Shah United Kingdom 19 3.3k 1.3× 2.8k 1.2× 1.1k 1.2× 708 1.5× 175 1.0× 48 3.9k
Maximiliano Van Kooten Argentina 9 3.7k 1.4× 3.3k 1.4× 1.1k 1.1× 623 1.3× 191 1.1× 14 4.5k
Katherine P. Sugarman United States 8 3.6k 1.4× 2.9k 1.2× 768 0.8× 629 1.3× 264 1.6× 10 4.2k
Zofia Piotrowska United States 26 2.1k 0.8× 1.7k 0.7× 938 1.0× 541 1.1× 128 0.8× 122 2.6k

Countries citing papers authored by C. Anger

Since Specialization
Citations

This map shows the geographic impact of C. Anger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Anger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Anger more than expected).

Fields of papers citing papers by C. Anger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Anger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Anger. The network helps show where C. Anger may publish in the future.

Co-authorship network of co-authors of C. Anger

This figure shows the co-authorship network connecting the top 25 collaborators of C. Anger. A scholar is included among the top collaborators of C. Anger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Anger. C. Anger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kafatos, George, Victoria Banks, David Neasham, et al.. (2021). Biomarker Testing and Mutation Prevalence in Metastatic Colorectal Cancer Patients in Five European Countries Using a Large Oncology Database. Future Oncology. 17(12). 1483–1494. 7 indexed citations
2.
Kafatos, George, Victoria Banks, David Neasham, et al.. (2021). Impact of Biomarkers and Primary Tumor Location on the Metastatic Colorectal Cancer First-Line Treatment Landscape in Five European Countries. Future Oncology. 17(12). 1495–1505. 2 indexed citations
3.
Mendoza, Luis, et al.. (2020). 774P Adoption of immune checkpoint inhibitors (ICIs) in bladder cancer: Findings from a real-world study in EU5. Annals of Oncology. 31. S595–S595. 1 indexed citations
4.
Smith, Bradley L., et al.. (2020). MSI/MMR test usage and checkpoint inhibitor practices in Europe.. Journal of Clinical Oncology. 38(15_suppl). e19327–e19327. 1 indexed citations
5.
6.
Anger, C., et al.. (2015). Evolution of RAS testing in colorectal cancer in France, Germany, Italy, Spain and UK (EU5).. Journal of Clinical Oncology. 33(15_suppl). e14679–e14679. 2 indexed citations
7.
Anger, C., et al.. (2015). Dose variation in metastatic breast cancer: Are European Medicines Agency summary of product characteristics (SmPC) being followed?. Journal of Clinical Oncology. 33(15_suppl). e11581–e11581. 2 indexed citations
8.
9.
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauro Zukin Breakdown of academic impact, for papers by Teresa Morán Breakdown of academic impact, for papers by Dae Ho Lee Breakdown of academic impact, for papers by Jennifer Tursi Breakdown of academic impact, for papers by Annetta Krebs Breakdown of academic impact, for papers by Riyaz Shah Breakdown of academic impact, for papers by Maximiliano Van Kooten Breakdown of academic impact, for papers by Katherine P. Sugarman Breakdown of academic impact, for papers by Zofia Piotrowska
Rankless by CCL
2026